DAILY NEWS SCIENTIFIC PROGRAMME
PRESIDENT'S CHOICE
This new session recognises the top abstract presentations across all four domains.
Issue 1 Thursday 5 October
The official newspaper of the 37th EACTS Annual Meeting 2023
BUILDING A HEALTHY FUTURE
This year's Honoured Guest speaker provides fascinating insights into the health challenges of Benin. Page 15
WELCOME TO VIENNA
RAISING THE BAR IN CARDIOTHORACIC SURGERY
Page 11 This year a record number of abstracts were submitted for consideration, showcasing the latest science and research. Our domains and task forces have worked hard reviewing and selecting the very best abstract presentations to feature in the scientific programme.
SHOWCASING INNOVATION
Techno-College leads the way at this year's Annual Meeting. Page 3
Patrick Myers EACTS Secretary General
In fact, such was the standard of submissions this year, that we will be presenting some abstracts in poster format. These are available to view around the conference centre and I encourage you all to read them. The top four abstracts across each domain will be presented during a new ‘President’s Choice’ plenary on Thursday morning.
I am delighted to welcome you all to the beautiful city of Vienna for the 37th EACTS Annual Meeting. It is a city that holds many good memories for EACTS as the home of our first Annual Meeting nearly 40 years ago.
In addition to excellent abstract sessions, we also have a first-class programme of talks by invited experts from around the world, who will share their knowledge and insights across many subjects. Over the next few pages our domain chairs have outlined some sessions you won’t want to miss.
The meeting has changed considerably since that time, growing in size and international reputation to become one of the largest events for the cardiothoracic community around the world.
Reviewing the latest guidelines and evidence From a personal point of view, I am looking forward to Saturday’s ‘Trial Update’ during which we will examine
the current progress and findings of major trials in our field, including the UK Mini Mitral Trial and the EVOLUT Low-Risk Trial. Last year we held two fantastic late breaking clinical trials sessions, and with an increasing number of highquality trials, I am delighted that we have had to increase to three late breaking sessions. We have selected the very best, high impact trials to be presented during the Annual Meeting, with selected manuscripts being published simultaneously in highimpact journals, so I urge everyone to attend these important sessions. The ‘2023 Guideline Session’ on Saturday morning is also not to be missed. Evidence-based clinical guidelines are critical for delivering the highest standards of patient care and EACTS has an active and influential role to inform clinical practice by developing new practice guidelines. Currently, we are working on 22 guidelines, many in collaboration with different organisations globally. We have selected some key guidelines to be presented and discussed by our different task forces and domains throughout the Annual Meeting,
continued page 2
Edwards Lifesciences Lunch Symposium
RESILIA tissue: what does it take to become a new standard? Thursday, October 5 2023 12:15 - 13:30 | Room: Hall E1
Chairs :
th
Joseph Bavaria
Edwards, Edwards Lifesciences, the stylized E logo, COMMENCE, INSPIRIS, INSPIRIS RESILIA, Magna and Magna Ease are trademarks or service marks of Edwards Lifesciences Corporation. © 2023 Edwards Lifesciences Corporation. All rights reserved. PP--EU-6989 v1.0 Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com
Martin Grabenwöger
Scan the QR code to learn more